Vytorin, Zetia Coverage In 2009 Among All Payers Still Solid But Slipping

Merck/Schering-Plough's cholesterol drugs Vytorin and Zetia will be reimbursed without restriction as preferred brands for about 67 percent of individuals enrolled in commercial and Medicare Part D plans in 2009, according to Merck